Abendan, Aiza .

HRN: 23-94-85  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/22/2023
AMPICILLIN 1GM (VIAL)
10/22/2023
10/23/2023
IV
2 Grams
Q6
PROM X 18 Hrs
Checking Final Appropriateness 
10/23/2023
CEFUROXIME 1.5GM (VIAL)
10/23/2023
10/24/2023
IV
1.5gm 3 Doses
Q8
S/P CS
Checking Final Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: